Glucagon-like peptide 1(glp-1) pharmaceutical formulations

Details Glucagon-like peptide 1(glp-1) pharmaceutical formulations Glucagon-like peptide 1(glp-1) pharmaceutical formulations

A - Human Necessities

61

K

A61K 9/16 (2006.01) A61K 38/26 (2006.01)

Patent

CA 2646400

A composition is disclosed comprising glucagon- like peptide 1 (GLP-I) particles in combination with diketopiperazine (DKP) that is stable both in vitro and in vivo. The composition has utility as a pharmaceutical formulation for treating diseases such as diabetes, cancers, and obesity but is not limited to such diseases or conditions. In particularly, the composition has utility as a pharmaceutical formulation for pulmonary delivery.

Composition à particules de peptide apparenté au glucagon 1(GLP-1) en combinaison avec la substance dikétopipérazine (DKP) stable, à la fois in vitro et in vivo, utile comme formulation pharmaceutique pour le traitement de maladies du type diabète, cancer, et obésité, sans limitation à ces cas, et en particulier utile comme formulation pharmaceutique aux fins de délivrance pulmonaire.

Affiliated with

Also associated with

Rating

Glucagon-like peptide 1(glp-1) pharmaceutical formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glucagon-like peptide 1(glp-1) pharmaceutical formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucagon-like peptide 1(glp-1) pharmaceutical formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1759958